title: AABB comments on the FDA's draft guidance on considerations for early phase clinical trials for cellular therapy products.
authors: Rafael K
authors: RK
authors: Cassata
mesh_terms: D017690:Cell Transplantation; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D017408:Guidelines as Topic; D006801:Humans; D012955:Societies, Medical; D014481:United States; D014486:United States Food and Drug Administration